Header Logo

The First 4 Years of Postmarketing Safety Surveillance Related to the MitraClip Device: A United States Food and Drug Administration MAUDE Experience.

Mahabir CA, DeFilippis EM, Aggarwal S, Bath A, Qamar A, Patel NK, Goldsweig AM, Vaduganathan M. The First 4 Years of Postmarketing Safety Surveillance Related to the MitraClip Device: A United States Food and Drug Administration MAUDE Experience. J Invasive Cardiol. 2020 05; 32(5):E130-E132.

View in: PubMed